Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Dornase alfa
Medication labelPULMOZYME® is indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis…
Why this: Advisory · dailymed-prescription
PULMOZYME® is indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function. In CF patients with an FVC ≥ 40% of predicted, daily administration of PULMOZYME has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics.
- generic_name
- dornase alfa
- product_names
- dornase alfa
- ndc
- 50242-100, 50242-100-39, 50242-100-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en